Unknown

Dataset Information

0

The atypical antipsychotic risperidone targets hypothalamic melanocortin 4 receptors to cause weight gain.


ABSTRACT: Atypical antipsychotics such as risperidone cause drug-induced metabolic syndrome. However, the underlying mechanisms remain largely unknown. Here, we report a new mouse model that reliably reproduces risperidone-induced weight gain, adiposity, and glucose intolerance. We found that risperidone treatment acutely altered energy balance in C57BL/6 mice and that hyperphagia accounted for most of the weight gain. Transcriptomic analyses in the hypothalamus of risperidone-fed mice revealed that risperidone treatment reduced the expression of Mc4r. Furthermore, Mc4r in Sim1 neurons was necessary for risperidone-induced hyperphagia and weight gain. Moreover, we found that the same pathway underlies the obesogenic effect of olanzapine-another commonly prescribed antipsychotic drug. Remarkably, whole-cell patch-clamp recording demonstrated that risperidone acutely inhibited the activity of hypothalamic Mc4r neurons via the opening of a postsynaptic potassium conductance. Finally, we showed that treatment with setmelanotide, an MC4R-specific agonist, mitigated hyperphagia and obesity in both risperidone- and olanzapine-fed mice.

SUBMITTER: Li L 

PROVIDER: S-EPMC8126977 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

2021-01-01 | GSE158751 | GEO
| PRJNA666420 | ENA
| PRJEB31532 | ENA
| S-EPMC5669575 | biostudies-literature
2021-01-01 | GSE157438 | GEO
| S-EPMC4166499 | biostudies-literature
| S-EPMC3693401 | biostudies-literature
| S-EPMC4266663 | biostudies-literature
| S-EPMC3501406 | biostudies-literature
| S-EPMC9523121 | biostudies-literature